Key Highlights

  • bioAffinity Technologies shares closed up 21% at $0.47.
  • The company partnered with SDVOSB AvMEDICAL to distribute CyPath Lung across federal healthcare networks.
  • The deal includes access to VA medical centers via government procurement.
  • Financial terms of the Partnership were not disclosed.

bioAffinity Technologies, Inc. (NASDAQ: BIAF) shares closed up 21% at $0.47 after the company partnered with SDVOSB AvMEDICAL to distribute CyPath Lung across federal healthcare networks, including VA medical centers.

What Happened

The partnership expands commercial access via government procurement channels, though the companies did not disclose financial terms of the arrangement.

Market Reaction

Shares rose as investors responded to the expanded distribution pathway into federal healthcare networks, viewing the government procurement channel as a meaningful new avenue for CyPath Lung's commercial reach.

Outlook

Continued expansion of CyPath Lung's access within VA medical centers and other federal healthcare networks is likely to remain relevant for bioAffinity Technologies' commercial trajectory going forward.